68-Ga-NYM032

DIAGNOSTIC_TEST2 trials

Sponsors

Norroy Bioscience Co., LTD

Conditions

Prostate CancerProstate Cancer (Diagnosis)

Phase 3

Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.

RecruitingNCT07615101

Norroy Bioscience Co., LTDProstate Cancer (Diagnosis)

Start: 2026-08-06End: 2027-07-30Target: 365Updated: 2026-08-17

This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.

RecruitingNCT07649122

Norroy Bioscience Co., LTDProstate Cancer

Start: 2026-08-31End: 2028-07-31Target: 232Updated: 2026-09-15